Medicines Transparency in the Philippines


Published on

Presentation on medicines transparency in the Philippines at the launch of the Medicines Transparency Alliance (MeTA) in London, May 2008

1 Like
  • Be the first to comment

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide
  • Title of presentation 04/06/09 MeTA
  • Medicines Transparency in the Philippines

    1. 1. MeTA Philippines: Sharing Responsibility, Achieving as One MeTA 06/04/09
    2. 2. 06/04/09 MeTA Introduction <ul><li>Philippines challenges and progress in access to medicines and improving governance and transparency </li></ul><ul><li>Early experience with using MeTA to bring stakeholders together to increase momentum towards these goals </li></ul><ul><li>What would other countries like to know about Philippines’ experience with setting up MeTA Council and national multistakeholder forum? </li></ul><ul><li>What would other countries like to know about pre-existing measures to increase transparency and governance in relation to medicines procurement and prices </li></ul>
    3. 3. Challenges in the Philippines <ul><li>High cost of medicines </li></ul><ul><li>Non transparent mechanisms of medicines pricing </li></ul><ul><li>High out-of-pocket payments – burdening the poor and the disadvantaged </li></ul><ul><li>Preference for branded medicines </li></ul><ul><li>Low availability in many local government health centers </li></ul>06/04/09 MeTA
    4. 4. Government Goals: <ul><li>Improve access to essential medicines by: </li></ul><ul><li>Cutting the price of essential medicines to 50 % from base prices in 2004 </li></ul><ul><li>Reducing out-of-pocket payments </li></ul><ul><li>Improving generic competition and assuring quality </li></ul><ul><li>Instituting mechanisms for transparency and good governance </li></ul><ul><li>Engaging local governments in these goals </li></ul>06/04/09 MeTA
    5. 5. Achievements and Strengths <ul><li>Strong civil society tradition </li></ul><ul><li>Health Reforms geared towards improved access </li></ul><ul><li>(Affordable and Quality medicines) </li></ul><ul><li>Reforms towards transparency, and good governnance </li></ul><ul><li>(Fourmula I) </li></ul><ul><li>DOH works with CSOs in monitoring procurement and distribution of medicines and advocating for legislation on access to medicines </li></ul><ul><li>Philippines national social health insurance fund </li></ul>
    6. 6. Basic Strategy 06/04/09 MeTA Multi-stakeholder Collaboration Sharing Responsibility, Achieving as One through
    7. 7. Building MeTA in the Philippines December 2007 Induction of Officers, & First National Multi-Stakeholder Forum (Launch) November, 2007 Election of Officers July to September, 2007 Invitation and enlisting of prospective members May to July, 2007 Technical Working Group Meetings to form MeTA Structure April 2007 Scoping Visit
    8. 8. Induction
    9. 9. The MeTA Stakeholders
    10. 10. Who are involved? <ul><li>The MeTA Council </li></ul><ul><li>24-member Council </li></ul><ul><li>Chaired by a former Health Secretary </li></ul>Phil Health Insurance Corporation, Phil International Trading Corporation, Local Government Service Providers Department of Health, Senate, House of Representatives Policy Makers Bureau of Food and Drugs, Commission on Audit, Dept of Budget Management Regulators, Oversight Agencies Professional Groups, Academe, NGO’s, CSO Watch Groups Civil Society Some MNCs, Philippines Chamber of Pharmaceuticals, Inc. Industry WHO, World Bank, EU, GTZ International Development Partners
    11. 11. How do we work? MeTA Council Administrative Committee Technical Committee Research and Assessments Secretariat and In- Country Coordinator (WHO Country Office ) MeTA Forum
    12. 12. How the Council Works <ul><li>Structure/Operations </li></ul><ul><li>Collegial body, each with one vote </li></ul><ul><li>Guided by an Internal Rules </li></ul><ul><li>Meets regularly every three months, with some </li></ul><ul><li>“ disciplinary” measures for non-active members </li></ul><ul><li>Function of Council </li></ul><ul><li>Propose policies for government and other sectors to act upon </li></ul><ul><li>Decides/votes on matters of membership, programmes, activities, etc </li></ul>
    13. 13. Little Big Wins <ul><li>Forging a strong multi stakeholder collaboration </li></ul><ul><li>Pooling resources and technical expertise to support government reforms </li></ul><ul><li>Policy inputs to major issues (Affordable and Quality Medicines Act of 2008, Pric Monitoring, Generics, TRIPs) </li></ul><ul><li>First to launch MeTA and National Forum on Medicines Transparency </li></ul><ul><li>Set up MeTA Council Office </li></ul>
    14. 14. Current Activities <ul><li>MeTA Assessment Package </li></ul><ul><ul><li>Facility and Household Survey (initial funding from WHO) </li></ul></ul><ul><ul><li>Assessment of LGU Procurements (tech support from EU) </li></ul></ul><ul><li>Development of the MeTA-Phil Website </li></ul><ul><li>Academic and technical discussions on issues surrounding the Cheaper Medicines Bill </li></ul><ul><li>National Awards for Good Governance in Medicines </li></ul><ul><ul><li>WHO-led </li></ul></ul><ul><li>The Philippines Pharmaceutical Benchbook </li></ul><ul><ul><li>WHO-led </li></ul></ul>
    15. 15. Integrating MeTA Support into Local reforms Health Reforms: FOURmula I for Health (F1) Service delivery Financing Regulations Good Governance MeTA Transparency and Good Governance Assessment and Technical Support Systems for proper resource management and building sustainable financing models Improved access and support to decentralized systems
    16. 16. Summary <ul><li>What has been learned: </li></ul><ul><li>A multi-stakeholder collaboration can work </li></ul><ul><li>Need for facilitating organization to coordinate and organize at country level </li></ul><ul><li>Willingness to share resources to jump start activities. </li></ul><ul><li>In-country initiative and ownership is important </li></ul>06/04/09 MeTA
    17. 17. Lessons Learned <ul><li>“ Every collaborator must concede a little…” </li></ul><ul><li>in order to gain more </li></ul>
    18. 18. Useful Information Available on Request <ul><li>MeTA Council documents </li></ul><ul><ul><li>Internal rules of the MeTA Council </li></ul></ul><ul><ul><li>Member Declaration of Interest </li></ul></ul><ul><ul><li>Proceedings of MeTA National Stakeholder Forum </li></ul></ul><ul><ul><li>Proceedings of Regular Meetings </li></ul></ul><ul><li>Government documents </li></ul><ul><ul><li>Philippines National Drug Policy </li></ul></ul><ul><ul><li>Philippines National Drug Formulary </li></ul></ul><ul><ul><li>DOH Administrative Order governing health reform (“FOURmula One”) </li></ul></ul><ul><ul><li>Cheaper Medicines Bill 2008 </li></ul></ul>06/04/09 MeTA
    19. 19. Thank You 06/04/09 MeTA